Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 18.86% Profit on QuantWave

May 03, 2023
On November 29, 2022, QuantWave issued a long forecast signal for ELI LILLY AND COMPANY stock when it was trading at 356.71 $. The prediction proved to be accurate as the stock reached the target price of 423.98 $ on May 3, 2023, delivering a profit of 18.86% to investors.

The success of this forecast underscores the effectiveness of QuantWave's analytics in predicting price movements in the stock market. Analyzing market trends and potential factors influencing ELI LILLY AND COMPANY's stock, QuantWave was able to provide valuable insights to its users, allowing them to capitalize on the opportunity and generate significant profits.

QuantWave's automated forecasting platform offers users predictions for a wide range of stocks, presenting numerous opportunities for potential profits. For those seeking a deeper understanding of QuantWave's investment strategy, QuantSchool provides valuable educational resources on how to utilize the forecasting system effectively. By following the key principles outlined in QuantSchool, investors can learn how to generate consistent income using QuantWave's advanced analytics.

In conclusion, the accomplishment of reaching the forecast price target for ELI LILLY AND COMPANY stock highlights the efficiency and reliability of QuantWave's forecasting capabilities, demonstrating its potential to guide investors towards successful trading decisions.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

PPLMarch 3, 2025QuantWave Achieves 17.2% Profit Target Forecast for PPL CORPORATION Stock  ~1 min.

QuantWave, the automated forecasting platform, recently celebrated a successful forecast for PPL CORPORATION stock, achieving a 17.2% profit as the price reached the predicted target....

BTC-USDNovember 21, 2024QuantWave Achieves 42.47% Profit Target Forecast for BITCOIN USD  ~1 min.

QuantWave, the automated forecasting platform, has successfully reached a price target forecast for the stock BITCOIN USD, generating a profit of 42.47%....

ABTJanuary 27, 2025ABBOTT LABORATORIES Hits Price Target Forecast with 9.36% Profit Margin  ~1 min.

On March 12, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES at a price of 117.28 $. Analysts predicted a positive movement in the stock....

EOGApril 4, 2025EOG Resources, Inc. Hits Price Target Forecast with 7.86% Profit - QuantWave Analysis  ~1 min.

EOG Resources, Inc. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 7.86% for investors....

CFApril 8, 2025CF Industries Holdings, Inc. Stock Hits Price Target Forecast, Yielding 13.97% Profit  ~1 min.

CF Industries Holdings, Inc. recently accomplished a significant milestone as it reached the price target forecast set by QuantWave, resulting in a profitable outcome for investors....